1,2-dimethylhydrazine increases expression ISO RGD:1558137 6480464 1, 2-Dimethylhydrazine results in increased expression of ERCC6L mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:1558137 6480464 Dinitrochlorobenzene results in increased expression of ERCC6L mRNA CTD PMID:18242016 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ERCC6L mRNA CTD PMID:30723492 17beta-estradiol increases expression ISO RGD:1606557 6480464 Estradiol results in increased expression of ERCC6L mRNA CTD PMID:19167446 , PMID:20106945 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1558137 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1558137 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1606557 6480464 Tetrachlorodibenzodioxin results in decreased expression of ERCC6L mRNA CTD PMID:21802500 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ERCC6L mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ERCC6L mRNA CTD PMID:22298810 3-methylcholanthrene increases expression ISO RGD:1558137 6480464 Methylcholanthrene results in increased expression of ERCC6L mRNA CTD PMID:20713471 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:1558137 6480464 Oxazolone results in increased expression of ERCC6L mRNA CTD PMID:18242016 4-hydroxynon-2-enal decreases expression ISO RGD:1558137 6480464 4-hydroxy-2-nonenal results in decreased expression of ERCC6L mRNA CTD PMID:19191707 acetamide increases expression EXP 6480464 acetamide results in increased expression of ERCC6L mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO RGD:1606557 6480464 Aflatoxin B1 affects the expression of ERCC6L protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of ERCC6L mRNA CTD PMID:23630614 aflatoxin B1 increases expression ISO RGD:1606557 6480464 Aflatoxin B1 results in increased expression of ERCC6L mRNA CTD PMID:22100608 aflatoxin B1 decreases expression ISO RGD:1558137 6480464 Aflatoxin B1 results in decreased expression of ERCC6L mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO RGD:1606557 6480464 Tretinoin results in decreased expression of ERCC6L mRNA CTD PMID:33167477 aristolochic acid decreases expression ISO RGD:1606557 6480464 aristolochic acid I results in decreased expression of ERCC6L mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:1606557 6480464 arsenite inhibits the reaction [G3BP1 protein binds to ERCC6L mRNA] CTD PMID:32406909 atrazine decreases expression ISO RGD:1606557 6480464 Atrazine results in decreased expression of ERCC6L mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:1606557 6480464 Benzo(a)pyrene results in decreased expression of ERCC6L mRNA CTD PMID:21802500 benzo[a]pyrene increases expression ISO RGD:1606557 6480464 Benzo(a)pyrene results in increased expression of ERCC6L mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:1606557 6480464 Benzo(a)pyrene affects the methylation of ERCC6L promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1606557 6480464 Benzo(a)pyrene results in increased methylation of ERCC6L exon CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1606557 6480464 7 more ... CTD PMID:20382639 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ERCC6L mRNA CTD PMID:25181051 bisphenol A increases methylation ISO RGD:1606557 6480464 bisphenol A results in increased methylation of ERCC6L gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ERCC6L mRNA CTD PMID:34947998 bisphenol A multiple interactions ISO RGD:1606557 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ERCC6L gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:1606557 6480464 bisphenol A results in decreased expression of ERCC6L mRNA CTD PMID:29275510 calcitriol multiple interactions ISO RGD:1606557 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of ERCC6L mRNA CTD PMID:21592394 calcitriol decreases expression ISO RGD:1606557 6480464 Calcitriol results in decreased expression of ERCC6L mRNA CTD PMID:21592394 carbamazepine affects expression ISO RGD:1606557 6480464 Carbamazepine affects the expression of ERCC6L mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1558137 6480464 Nanotubes more ... CTD PMID:25554681 choline multiple interactions ISO RGD:1558137 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ERCC6L mRNA CTD PMID:20938992 chromium(6+) affects expression ISO RGD:1558137 6480464 chromium hexavalent ion affects the expression of ERCC6L mRNA CTD PMID:28472532 copper(II) sulfate decreases expression ISO RGD:1606557 6480464 Copper Sulfate results in decreased expression of ERCC6L mRNA CTD PMID:19549813 coumestrol increases expression ISO RGD:1606557 6480464 Coumestrol results in increased expression of ERCC6L mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1606557 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 cyclosporin A decreases expression ISO RGD:1606557 6480464 Cyclosporine results in decreased expression of ERCC6L mRNA CTD PMID:19159671 , PMID:25562108 diethyl maleate increases expression EXP 6480464 diethyl maleate results in increased expression of ERCC6L mRNA CTD PMID:21161181 dioxygen decreases expression ISO RGD:1606557 6480464 Oxygen deficiency results in decreased expression of ERCC6L mRNA CTD PMID:17175027 , PMID:26516004 Enterolactone multiple interactions ISO RGD:1606557 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ERCC6L mRNA CTD PMID:19167446 enzyme inhibitor multiple interactions ISO RGD:1606557 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ERCC6L protein CTD PMID:23301498 folic acid multiple interactions ISO RGD:1558137 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ERCC6L mRNA CTD PMID:20938992 folic acid multiple interactions ISO RGD:1606557 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of ERCC6L mRNA CTD PMID:24657277 fulvestrant multiple interactions ISO RGD:1606557 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ERCC6L gene CTD PMID:31601247 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of ERCC6L mRNA CTD PMID:33387578 hydrogen peroxide multiple interactions ISO RGD:1558137 6480464 [Hydrogen Peroxide co-treated with N-(oxo-5 more ... CTD PMID:31494107 L-methionine multiple interactions ISO RGD:1558137 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ERCC6L mRNA CTD PMID:20938992 leflunomide decreases expression ISO RGD:1606557 6480464 leflunomide results in decreased expression of ERCC6L mRNA CTD PMID:28988120 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of ERCC6L mRNA CTD PMID:35283115 lucanthone decreases expression ISO RGD:1606557 6480464 Lucanthone results in decreased expression of ERCC6L mRNA CTD PMID:21148553 manganese atom decreases expression ISO RGD:1606557 6480464 Manganese results in decreased expression of ERCC6L mRNA CTD PMID:17175027 manganese(0) decreases expression ISO RGD:1606557 6480464 Manganese results in decreased expression of ERCC6L mRNA CTD PMID:17175027 manganese(II) chloride decreases expression ISO RGD:1606557 6480464 manganese chloride results in decreased expression of ERCC6L mRNA CTD PMID:17175027 MeIQx increases expression ISO RGD:1606557 6480464 2-amino-3 more ... CTD PMID:20816883 methotrexate multiple interactions ISO RGD:1606557 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of ERCC6L mRNA CTD PMID:24657277 methotrexate decreases expression ISO RGD:1606557 6480464 Methotrexate results in decreased expression of ERCC6L mRNA CTD PMID:24657277 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of ERCC6L mRNA CTD PMID:19041683 N-Nitrosopyrrolidine decreases expression ISO RGD:1606557 6480464 N-Nitrosopyrrolidine results in decreased expression of ERCC6L mRNA CTD PMID:32234424 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ERCC6L mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of ERCC6L mRNA CTD PMID:25729387 paracetamol increases expression ISO RGD:1606557 6480464 Acetaminophen results in increased expression of ERCC6L mRNA CTD PMID:22230336 PCB138 multiple interactions ISO RGD:1558137 6480464 [2 more ... CTD PMID:25510870 phenethyl isothiocyanate decreases expression ISO RGD:1606557 6480464 phenethyl isothiocyanate results in decreased expression of ERCC6L mRNA CTD PMID:26678675 phenobarbital affects expression ISO RGD:1558137 6480464 Phenobarbital affects the expression of ERCC6L mRNA CTD PMID:23091169 pirinixic acid multiple interactions ISO RGD:1558137 6480464 [pirinixic acid co-treated with PPARA] results in increased expression of ERCC6L mRNA CTD PMID:20813756 pirinixic acid increases expression ISO RGD:1558137 6480464 pirinixic acid results in increased expression of ERCC6L mRNA CTD PMID:20813756 quercetin decreases expression ISO RGD:1606557 6480464 Quercetin results in decreased expression of ERCC6L mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:1606557 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of ERCC6L mRNA CTD PMID:19167446 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of ERCC6L mRNA CTD PMID:28374803 Senkirkine increases expression EXP 6480464 senkirkine results in increased expression of ERCC6L mRNA CTD PMID:32419051 silicon dioxide increases expression ISO RGD:1606557 6480464 Silicon Dioxide analog results in increased expression of ERCC6L mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:1558137 6480464 Silicon Dioxide results in increased expression of ERCC6L mRNA CTD PMID:29341224 silicon dioxide decreases expression ISO RGD:1606557 6480464 Silicon Dioxide analog results in decreased expression of ERCC6L mRNA CTD PMID:23806026 sodium arsenite decreases expression ISO RGD:1558137 6480464 sodium arsenite results in decreased expression of ERCC6L mRNA CTD PMID:17998272 sodium arsenite increases expression ISO RGD:1606557 6480464 sodium arsenite results in increased expression of ERCC6L mRNA CTD PMID:29301061 , PMID:34032870 sodium arsenite affects methylation ISO RGD:1606557 6480464 sodium arsenite affects the methylation of ERCC6L gene CTD PMID:28589171 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of ERCC6L mRNA CTD PMID:22110744 sunitinib decreases expression ISO RGD:1606557 6480464 Sunitinib results in decreased expression of ERCC6L mRNA CTD PMID:31533062 testosterone multiple interactions ISO RGD:1606557 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of ERCC6L mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1606557 6480464 Testosterone results in decreased expression of ERCC6L mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:1558137 6480464 Carbon Tetrachloride results in increased expression of ERCC6L mRNA CTD PMID:17484886 thapsigargin decreases expression ISO RGD:1606557 6480464 Thapsigargin results in decreased expression of ERCC6L mRNA CTD PMID:22378314 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ERCC6L mRNA CTD PMID:23411599 , PMID:34492290 toluene 2,4-diisocyanate increases expression ISO RGD:1558137 6480464 Toluene 2, 4-Diisocyanate results in increased expression of ERCC6L mRNA CTD PMID:18242016 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ERCC6L mRNA CTD PMID:25729387 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of ERCC6L mRNA CTD PMID:33387578 triclosan decreases expression ISO RGD:1606557 6480464 Triclosan results in decreased expression of ERCC6L mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO RGD:1558137 6480464 trimellitic anhydride results in increased expression of ERCC6L mRNA CTD PMID:19042947 tunicamycin decreases expression ISO RGD:1606557 6480464 Tunicamycin results in decreased expression of ERCC6L mRNA CTD PMID:22378314